FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2592855377> ?p ?o ?g. }

• W2592855377 endingPage "32607" @default.
• W2592855377 startingPage "32600" @default.
• W2592855377 abstract "// Ailin Song 1, * , Farong Liu 2, * , Lupeng Wu 2 , Xiaoying Si 2 , Yanming Zhou 2 1 Department of General Surgery, Second Hospital of Lanzhou University, Lanzhou, China 2 Department of Hepatobiliary and Pancreatovascular Surgery, First affiliated Hospital of Xiamen University, Xiamen, China * These authors contributed equally to this work Correspondence to: Yanming Zhou, email: zhouymsxy@sina.cn Keywords: pancreatic adenocarcinoma, survival, prognosis, superior mesenteric vein, portal vein Received: October 12, 2016      Accepted: February 22, 2017      Published: March 06, 2017 ABSTRACT BACKGROUND: The impact of histopathologic tumor invasion of the superior mesenteric vein (SMV)/portal vein (PV) on prognosis in patients with pancreatic ductal adenocarcinoma (PDAC) after pancreatectomy remains controversial. A meta-analysis was performed to assess this issue. RESULTS: Eighteen observational studies comprising 5242 patients were eligible, of whom 2199 (41.9%) patients received SMV/PV resection. Histopathologic tumor invasion was detected in 1218 (58.1%) of the 2096 resected SMV/PV specimens. SMV/PV invasion was associated with higher rates of poor tumor differentiation ( P = 0.002), lymph node metastasis ( P < 0.001), perineural invasion ( P < 0.001), positive resection margins ( P = 0.004), and postoperative tumor recurrence ( P < 0.001). SMV/PV invasion showed a significantly negative effect on survival in total patients who underwent pancreatectomy with and without SMV/PV resection (hazard ratio [HR]: 1.21, 95% confidence interval [CI]: 1.08–1.35; P = 0.001) and in patients who underwent pancreatectomy with SMV/PV resection (HR: 1.88, 95% CI, 1.48–2.39; P < 0.001). MATERIALS AND METHODS: A systematic literature search was performed to identify articles published from January 2000 to August 2016. Data were pooled for meta-analysis using Review Manager 5.3. CONCLUSIONS: Histopathologic tumor invasion of the SMV/PV is associated with more aggressive biologic behavior and could be used as an indicator of poor prognosis after PDAC resection." @default.
• W2592855377 created "2017-03-16" @default.
• W2592855377 creator A5027306441 @default.
• W2592855377 creator A5031497262 @default.
• W2592855377 creator A5049481173 @default.
• W2592855377 creator A5063101125 @default.
• W2592855377 creator A5091192631 @default.
• W2592855377 date "2017-03-06" @default.
• W2592855377 modified "2023-10-16" @default.
• W2592855377 title "Histopathologic tumor invasion of superior mesenteric vein/ portal vein is a poor prognostic indicator in patients with pancreatic ductal adenocarcinoma: results from a systematic review and meta-analysis" @default.
• W2592855377 cites W1486602565 @default.
• W2592855377 cites W1907201680 @default.
• W2592855377 cites W1970243664 @default.
• W2592855377 cites W1971281042 @default.
• W2592855377 cites W1982143114 @default.
• W2592855377 cites W1983394150 @default.
• W2592855377 cites W1986190753 @default.
• W2592855377 cites W1989909609 @default.
• W2592855377 cites W1991708979 @default.
• W2592855377 cites W1998863766 @default.
• W2592855377 cites W2001524386 @default.
• W2592855377 cites W2008227389 @default.
• W2592855377 cites W2012005360 @default.
• W2592855377 cites W2038726794 @default.
• W2592855377 cites W2042477712 @default.
• W2592855377 cites W2046112168 @default.
• W2592855377 cites W2059422746 @default.
• W2592855377 cites W2068269152 @default.
• W2592855377 cites W2072166355 @default.
• W2592855377 cites W2075642745 @default.
• W2592855377 cites W2094365026 @default.
• W2592855377 cites W2137517323 @default.
• W2592855377 cites W2146997862 @default.
• W2592855377 cites W2156098321 @default.
• W2592855377 cites W2231245238 @default.
• W2592855377 cites W2277384196 @default.
• W2592855377 cites W249044166 @default.
• W2592855377 cites W2513802192 @default.
• W2592855377 cites W2991792334 @default.
• W2592855377 cites W4211208840 @default.
• W2592855377 doi "https://doi.org/10.18632/oncotarget.15938" @default.
• W2592855377 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5464812" @default.
• W2592855377 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28427231" @default.
• W2592855377 hasPublicationYear "2017" @default.
• W2592855377 type Work @default.
• W2592855377 sameAs 2592855377 @default.
• W2592855377 citedByCount "13" @default.
• W2592855377 countsByYear W25928553772018 @default.
• W2592855377 countsByYear W25928553772019 @default.
• W2592855377 countsByYear W25928553772020 @default.
• W2592855377 countsByYear W25928553772021 @default.
• W2592855377 countsByYear W25928553772022 @default.
• W2592855377 countsByYear W25928553772023 @default.
• W2592855377 crossrefType "journal-article" @default.
• W2592855377 hasAuthorship W2592855377A5027306441 @default.
• W2592855377 hasAuthorship W2592855377A5031497262 @default.
• W2592855377 hasAuthorship W2592855377A5049481173 @default.
• W2592855377 hasAuthorship W2592855377A5063101125 @default.
• W2592855377 hasAuthorship W2592855377A5091192631 @default.
• W2592855377 hasBestOaLocation W25928553771 @default.
• W2592855377 hasConcept C121608353 @default.
• W2592855377 hasConcept C126322002 @default.
• W2592855377 hasConcept C126838900 @default.
• W2592855377 hasConcept C141071460 @default.
• W2592855377 hasConcept C207103383 @default.
• W2592855377 hasConcept C2777154038 @default.
• W2592855377 hasConcept C2777575454 @default.
• W2592855377 hasConcept C2778494859 @default.
• W2592855377 hasConcept C2778764654 @default.
• W2592855377 hasConcept C2779033008 @default.
• W2592855377 hasConcept C2780210213 @default.
• W2592855377 hasConcept C2781182431 @default.
• W2592855377 hasConcept C44249647 @default.
• W2592855377 hasConcept C71924100 @default.
• W2592855377 hasConcept C90924648 @default.
• W2592855377 hasConceptScore W2592855377C121608353 @default.
• W2592855377 hasConceptScore W2592855377C126322002 @default.
• W2592855377 hasConceptScore W2592855377C126838900 @default.
• W2592855377 hasConceptScore W2592855377C141071460 @default.
• W2592855377 hasConceptScore W2592855377C207103383 @default.
• W2592855377 hasConceptScore W2592855377C2777154038 @default.
• W2592855377 hasConceptScore W2592855377C2777575454 @default.
• W2592855377 hasConceptScore W2592855377C2778494859 @default.
• W2592855377 hasConceptScore W2592855377C2778764654 @default.
• W2592855377 hasConceptScore W2592855377C2779033008 @default.
• W2592855377 hasConceptScore W2592855377C2780210213 @default.
• W2592855377 hasConceptScore W2592855377C2781182431 @default.
• W2592855377 hasConceptScore W2592855377C44249647 @default.
• W2592855377 hasConceptScore W2592855377C71924100 @default.
• W2592855377 hasConceptScore W2592855377C90924648 @default.
• W2592855377 hasIssue "20" @default.
• W2592855377 hasLocation W25928553771 @default.
• W2592855377 hasLocation W25928553772 @default.
• W2592855377 hasLocation W25928553773 @default.
• W2592855377 hasLocation W25928553774 @default.
• W2592855377 hasOpenAccess W2592855377 @default.
• W2592855377 hasPrimaryLocation W25928553771 @default.
• W2592855377 hasRelatedWork W1985325263 @default.

• next